Moreover, targeting placental growth factor (PlGF)/NRP1 with monoclonal antibodies induced a direct antitumor effect in MB, resulting in tumor regression, decrease of metastasis and increase of survival in mouse models [12]. Here, PGF is linked to neoplasm.